Engineered receptor-biased IL-2–drug immunoconjugates selectively expand Tregs and suppress effector cells for autoimmune therapy. // Chinese General Practice Journal. – URL: https://www.sciencedirect.com/science/article/pii/S2666379126005446?dgcid=rss_sd_all
Engineered receptor-biased IL-2–drug immunoconjugates selectively expand Tregs and suppress effector cells for autoimmune therapy. Chinese General Practice Journal. https://www.sciencedirect.com/science/article/pii/S2666379126005446?dgcid=rss_sd_all
“Engineered receptor-biased IL-2–drug immunoconjugates selectively expand Tregs and suppress effector cells for autoimmune therapy.” Chinese General Practice Journal.
@article{article4638,
title = {Engineered receptor-biased IL-2–drug immunoconjugates selectively expand Tregs and suppress effector cells for autoimmune therapy},
journal = {Chinese General Practice Journal},
url = {https://www.sciencedirect.com/science/article/pii/S2666379126005446?dgcid=rss_sd_all}
}
Publication date: December 2026 Source: Journal of Electromyography and Kinesiology, Volume 91 Author(s): Pierre Garnault, Yannick Aoustin, Vigen Arakelian
Publication date: December 2026 Source: Journal of Electromyography and Kinesiology, Volume 91 Author(s): Mihailo Petrovic, Ann-Katrin Stensdotter, Helena Grip
Publication date: December 2026 Source: Journal of Electromyography and Kinesiology, Volume 91 Author(s): Michael Croskery, Victor Chan, Ryan B. Graham